# EDGAR Filing Document

**Accession Number:** 0002035992
**File Stem:** 0001213900-25-092640
**Filing Date:** 2025-9
**Character Count:** 2562
**Document Hash:** 10899220a651681e684eb482d36b32ad
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-25-092640.hdr.sgml**: 20260325

**ACCESSION NUMBER**: 0001213900-25-092640

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250929

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Charming Medical Ltd
- **CENTRAL INDEX KEY:** 0002035992
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 000000000

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** UNITS 1803-1U806, 18/F, HANG LUNG CENTRE
- **STREET 2:** 2-20 PATERSON STREET, CAUSEWAY BAY
- **CITY:** HONG KONG
- **STATE:** K3
- **ZIP:** 00000
- **BUSINESS PHONE:** 852 2116 1492

**MAIL ADDRESS:**
- **STREET 1:** UNITS 1803-1U806, 18/F, HANG LUNG CENTRE
- **STREET 2:** 2-20 PATERSON STREET, CAUSEWAY BAY
- **CITY:** HONG KONG
- **STATE:** K3
- **ZIP:** 00000

September 29, 2025

**<u>VIA EDGAR</u>**

Division of Corporation Finance

U.S. Securities & Exchange Commission

100 F Street, NE

Washington, D.C. 20549

---

| | |
|:---|:---|
| Re: | **Charming Medical Limited (CIK: 0002035992)** |
|  | **Registration Statement on Form F-1 (File No. 333-287258) (the *"Registration Statement"*)** |

---

Ladies and Gentlemen:

Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the ***"Act"***), the undersigned, for itself and the other underwriters, hereby joins in the request of Charming Medical Limited that the effective date of the above-referenced registration statement be accelerated so as to permit it to become effective at 5:15 p.m., Eastern time, on Tuesday, September 30, 2025, or as soon thereafter as practicable.

Pursuant to 460 under the Act, we wish to advise you that the underwriters have distributed as many electronic copies of the proposed form of preliminary prospectus to underwriters, dealers, institutions and others as appears to be reasonable to secure adequate distribution of such preliminary prospectus.

The undersigned advises that it has complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

---

| | |
|:---|:---|
| Very truly yours, | Very truly yours, |
| Cathay Securities, Inc. | Cathay Securities, Inc. |
| *As representative of the underwriters* | *As representative of the underwriters* |
| By: | */s/ Shell Li* |
| Name: | Xiaoyu (Shell) Li |
| Title: | Chief Executive Officer |

---